TL;DR
Get beauty and skincare favorites delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
PAI Partners has agreed to acquire British prestige skincare brand Elemis from L’Occitane Group, which has owned it since 2019. The deal is expected to close in the first quarter of 2027, subject to regulatory approvals; financial terms have not been disclosed.
PAI Partners has agreed to acquire Elemis, the British prestige skincare brand, from L’Occitane Group, ending the group’s seven years of ownership. The transaction was announced on November 4, 2026, and is expected to close in the first quarter of 2027, subject to regulatory approvals; financial terms were not disclosed.
Elemis has grown since L’Occitane acquired it in 2019. According to the source report, the brand’s annual net sales nearly doubled to more than US$300 million in fiscal 2026. The report says the United States now represents about 50 percent of revenue, while digital channels account for nearly half of total sales. Those figures indicate the scale and reach of the business being transferred, but do not disclose its profitability or valuation.
PAI’s stated plans focus on further growth: strengthening Elemis’s position in the UK, accelerating its US business, and expanding digital and premium retail distribution. The firm also plans to continue investing in Elemis’s Pro-Collagen portfolio. The announcement does not provide a detailed operating plan, investment amount or timetable for those initiatives.
The agreement remains subject to regulatory approvals, so the ownership change has not yet been completed. Until closing, Elemis remains part of L’Occitane Group. No purchase price or other financial terms have been made public in the source material.
Elemis’s Next Growth Phase
The agreement places Elemis under a new owner as it seeks to build on a business with more than US$300 million in fiscal 2026 net sales and substantial US and online revenue. PAI’s announced priorities point to expansion through established channels as well as greater investment in digital and premium retail distribution. Whether those plans lead to further growth will depend on execution and market conditions; the announcement provides no forecast.
For L’Occitane Group, the sale is a portfolio decision that ends its ownership of Elemis, but the group has not explained its reasons for the divestment in the information provided. For PAI, the acquisition adds a well-established skincare brand to its portfolio. The transaction also reflects private equity interest in prestige beauty businesses with international distribution and digital sales, though the announcement alone does not establish how common or profitable such investments are.
Consumers and retail partners may want to know whether the change will affect products, prices, distribution or the brand’s existing business relationships. No such changes were detailed in the announcement. The stated intention to keep investing in Pro-Collagen suggests continuity in that portfolio, but does not settle wider questions about product strategy or future availability.
Products Worth Considering
Garmin Forerunner 55 GPS Running Smartwatch, Black
Levoit Vital 100S-P Air Purifier with Washable Pre-Filter
Levoit Core 400S-P Smart Air Purifier for Large Rooms
As an affiliate, we earn on qualifying purchases.
Seven Years Under L’Occitane
L’Occitane Group acquired Elemis in 2019. The reported growth since then provides the immediate business context for the agreement: annual net sales nearly doubled to more than US$300 million in fiscal 2026, with the US contributing approximately half of revenue and digital channels generating nearly half of total sales. The source report does not provide the starting sales figure or detailed year-by-year results.
The deal is part of a broader pattern of private equity firms pursuing established beauty brands, according to the source report. In this case, PAI’s plans are specifically tied to Elemis’s UK position, US growth, online sales, premium retail distribution and Pro-Collagen products. These are announced priorities, not evidence that the company has already made changes under the proposed ownership.
“PAI Partners plans to strengthen Elemis’s UK market position, accelerate US growth and expand digital and premium retail distribution, while continuing investment in its Pro-Collagen skincare portfolio.”
— PAI Partners
Deal Terms and Approval Status
The purchase price and financial terms have not been disclosed. The source material also does not identify the regulators whose approval is required or report whether any approvals have been granted. The transaction is therefore an agreement to acquire Elemis, not a completed transfer of ownership.
Other details remain unconfirmed, including how PAI will finance the purchase, whether Elemis will retain its current leadership and workforce, and whether the deal will affect products, prices, suppliers or retail arrangements. The announcement gives no financial projections or specific milestones for the planned expansion. It also does not explain L’Occitane Group’s rationale for selling.
Approval Before the Handover
The next major milestone is regulatory review. The parties expect the transaction to close in the first quarter of 2027, provided the required approvals are obtained. That timing is an expectation rather than a confirmed completion date; the source material does not state what would happen if review takes longer.
Until closing, Elemis remains under L’Occitane Group. Further disclosures could clarify the deal’s financial terms, the approvals process and any operational arrangements for the handover. After completion, PAI’s stated focus will be on UK positioning, US growth, digital and premium retail distribution, and continued investment in Pro-Collagen. The announcement does not give dates or measurable targets for those plans.
Key Questions
Who has agreed to acquire Elemis?
PAI Partners has agreed to acquire the skincare brand from L’Occitane Group. The transaction has not yet closed.
When is the deal expected to close?
The parties expect completion in the first quarter of 2027, subject to regulatory approvals. The exact closing date has not been announced.
How much is PAI paying for Elemis?
The financial terms have not been disclosed. The source material gives no purchase price or financing details.
What does PAI plan to do with Elemis?
PAI says it plans to strengthen Elemis in the UK, accelerate growth in the US, expand digital and premium retail distribution, and continue investment in the Pro-Collagen portfolio. No timetable or growth targets were provided.
How has Elemis performed under L’Occitane?
The source report says annual net sales nearly doubled to more than US$300 million in fiscal 2026. It also reports that the US accounts for about half of revenue and digital channels generate nearly half of sales. The report does not give profitability figures or year-by-year results.
Source: globalcosmeticsnews.com
